While it’s not as well-known as, say, leukemia or melanoma, multiple myeloma is the second most common blood cancer in adults, according to the Cancer Research Institute. “Multiple myeloma is a cancer ...
Multiple myeloma is a chronic blood cancer affecting plasma cells, but with today’s treatments many patients can manage symptoms and live fulfilling lives. Multiple myeloma is a cancer that begins in ...
Black survivors of multiple myeloma say the latest developments in treatment give them hope even as federal research cuts ...
The Food and Drug Administration granted fast track designation to HDP-101 for the treatment of multiple myeloma. The U.S.
Multiple myeloma happens when the bone marrow makes abnormal white ... “Some patients relapse early after treatment, even though they didn’t show any known high-risk signs at diagnosis.” The study, ...
A quadruplet regimen for treating transplant-ineligible, newly diagnosed multiple myeloma (MM), combining the oral drug ixazomib with daratumumab, lower-dose lenalidomide, and dexamethasone (Dara-RId) ...
Multiple myeloma occurs when the bone marrow makes abnormal white ... “Some patients relapse early after treatment, even though they didn’t show any known high-risk signs at diagnosis.” The study, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results